Aspire Private Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-7
| Closed | -$286 | – | 354 |
|
2024
Q3 | $286 | Hold |
7
| – | – | ﹤0.01% | 634 |
|
2024
Q2 | $270 | Hold |
7
| – | – | ﹤0.01% | 649 |
|
2024
Q1 | $300 | Hold |
7
| – | – | ﹤0.01% | 674 |
|
2023
Q4 | $259 | Hold |
7
| – | – | ﹤0.01% | 666 |
|
2023
Q3 | $253 | Hold |
7
| – | – | ﹤0.01% | 664 |
|
2023
Q2 | $249 | Hold |
7
| – | – | ﹤0.01% | 639 |
|
2023
Q1 | $249 | Hold |
7
| – | – | ﹤0.01% | 618 |
|
2022
Q4 | $246 | Hold |
7
| – | – | ﹤0.01% | 620 |
|
2022
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 631 |
|
2021
Q1 | – | Sell |
-3
| Closed | – | – | 563 |
|
2020
Q4 | $0 | Sell |
3
-6,715
| -100% | – | ﹤0.01% | 484 |
|
2020
Q3 | $316K | Sell |
6,718
-1,521
| -18% | -$71.5K | 0.13% | 87 |
|
2020
Q2 | $426K | Sell |
8,239
-1,369
| -14% | -$70.8K | 0.2% | 70 |
|
2020
Q1 | $455K | Sell |
9,608
-938
| -9% | -$44.4K | 0.25% | 64 |
|
2019
Q4 | $619K | Sell |
10,546
-347
| -3% | -$20.4K | 0.27% | 68 |
|
2019
Q3 | $581K | Sell |
10,893
-412
| -4% | -$22K | 0.28% | 66 |
|
2019
Q2 | $566K | Sell |
11,305
-1,865
| -14% | -$93.4K | 0.27% | 77 |
|
2019
Q1 | $688K | Sell |
13,170
-1,632
| -11% | -$85.3K | 0.35% | 63 |
|
2018
Q4 | $707K | Buy |
+14,802
| New | +$707K | 0.41% | 55 |
|